Tracking Bossche Vaccine related Virus Escape
My understanding of the Geert Vanden Bossche hypothesis might be summarized as follows:
The Vaccines are highly effective, but narrowly focused on a specific spike protein configuration. As such at some point they will be evaded by future viral variants.
As such, vaccination amidst a population where many are carrying the virus has the potential to guide evolution to favor new variants that avoid the protection afforded by the vaccine.
He also seems to be dismissive of anti-viral like IVM as a way of decreasing the prevalence of C19 in the population as he suspects a similar evolutionary response as with antibiotics.
If the Bossche hypothesis is correct we would expect to see new variants popping up more frequently in parts of the world where vaccines are most prevalent.
The variants that I am aware seem to have occurred prior to vaccine adoption.
Two Original Wuhan Variants, UK Variant, Brazil Variant, South African Variant all were present prior to the vaccines.
I have heard now of an India Variant which is more recent. However India is rather recent to receiving vaccines.
Are there any US or Euro variants that might indicate Vaccine related effects on the viral evolution and provide support for the Viral Escape Hypothesis?
IVM seems like it is breaking thru and will hopefully become the standard of care. Yay FLCCC!
Given the fear of vaccine escape, it seems like IVM and other anti-virals distributed widely to tamp down the quantity of infected, followed up by mass vaccine rollout would meet the criteria that Bossche suggests for the vaccine to be highly effective @ eliminating c19 and not having to endlessly fight variants on into the future.
I feel this is a possible path forward as IVM and the vaccines continue to develop a track record of effectiveness and safety.
As Biden is indicating support for removal of patent enforcement to enable rollout of Vaccines quickly. Much of the profit motive that has squashed IVM will seemingly ease.
Perhaps this will allow IVM to suddenly become the wonder drug and rollout very quickly, with the vaccines to follow as the one two punch.
The variants seemed to have popped up in the places where the vaccines were trialed.
Hopefully you are correct about IVM breaking through the noise!
It’s hard to find answers when stats are manipulated and adverse events are underreported and the ct threshold has recently changed. I hope you are right in suggesting that vaccines don’t exacerbate the evolution of variants, but I’ll take facts over hope any day.
Because they are not able to “kill the virus completely” in each vaccinated person, it remains to smolder away and to mutate in ways that favor more virulence. So the vaccines, as they are, could be causing the variants. But, yes, I believe it is correct to say that widespread use of IVM, even among the vaccinated, could “kill” the thing off.
But I heard a rep of CDC saying on Public Radio this evening, that the findings since the vaccine has been applied to the population, shows that it is 90% effective at preventing infection!!! And, those who do get it are either asymptomatic or only have mild symptoms. I’d like to see that finding. This is supposed to be why CDC is now saying that those with up to date vaccines don’t have to wear a mask any more. News this evening.
That would destroy Big Pharma’s plan to put out endless endemic vaccines though. So…not sure IVM will be getting the green light yet.
If these vaccines were 100% effective at creating a nearly perfect, or sterilizing level of immunity, there would be no concern for the kind of breakthrough that concerns Bossche.. but they are not. People can and do still become infected, which sets up the conditions for what has been described in the interview between Geert and Bret Weinstein as setting up a giant population-level gain-of-function experiment.
Secondly, Dr. Geert mentions in almost every interview that lockdowns have a similar effect in terms of evolutionary pressure on the virus as do the leaky vaccines… since the transmissibility is highly dependent on functions contained in the spike protein. So by his theory, spike protein variants could have and should have started emerging even before the vaccine.
I think the situation is actually worse than even Geert imagines because we have this phenomenon whereby there appears to be some kind of immune suppression, especially among the elderly, in the two weeks following jab #1. This is why Covid-19 has swept through nursing or care homes post vaccination campaigns in these facilities. Just imagine the accelerated immune escape (selection) kinetics involved in that scenario. The vaccine against the original wild type Wuhan strain is already failing demonstrably….
Another striking finding of the present study is the reduced neutralizing response observed towards the 20H/501Y.V2 variant in fully-immunized subjects with the BNT162b2 107 vaccine by comparison to the wild type and 20I/501Y.V1 variant.
I have read that there are in the range of 40,000 variants. Obviously some much more of a concern than others. I have also read that no variants resulted from the 2018 flu epidemic. I’m not sure about either claim.
Most of Geert’s arguments appear to focus on the leaky attributes of the vaccines and the period of suboptimal immune systems, in both the vaccinated and the recently infected.
And how about the flood of infected immigrants who are being shipped via public transportation throughout the hinterlands from the open southern border. Surely that is continuing to feed the beast in some respect.
Here is a graph of all the different variants found to date.